MARKET

SQNMF

SQNMF

Sequana Medical
Grey
--
NaN%
Opening
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M
Seeking Alpha · 03/19 17:09
About SQNMF
Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Webull offers Sequana Medical NV stock information, including Grey: SQNMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SQNMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SQNMF stock methods without spending real money on the virtual paper trading platform.